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One of the major instigators leading to neuronal cell death and brain damage following cerebral ischemia is calcium dysregulation.
The neuron’s inability to maintain calcium homeostasis is believed to be a result of increased calcium inﬂux and impaired calcium
extrusion across the plasma membrane. The need to better understand the cellular and biochemical mechanisms of calcium
dysregulation contributing to neuronal loss following stroke/cerebral ischemia is essential for the development of new treatments
in order to reduce ischemic brain injury. The aim of this paper is to provide a concise overview of the various calcium inﬂux
pathways in response to ischemia and how neuronal cells attempts to overcome this calcium overload.
1.Introduction
1.1. Cerebral Ischemia and Neuronal Cell Death. Cerebral
ischemia results in a reduced blood supply to brain tissue,
causing oxygen-glucose deprivation and ATP production
failure. The resulting energy crisis can trigger a cascade of
detrimental biochemical and physiological events leading to
acute or delayed cell death [1]. The lack of ATP synthesis
causes the loss of ion homeostasis, resulting in membrane
depolarisation and release of the neurotransmitter glu-
tamate. High extracellular glutamate causes excitotoxicity
resulting in NMDA, AMPA, and kainic acid receptor acti-
vation allowing the inﬂux of calcium, sodium, and zinc
ions into the cell. If ATP synthesis inhibition is sustained,
acute cell death occurs. If ATP synthesis is transiently or
mildly inhibited, delayed cell death can occur. In acute
cell death, excessive intracellular calcium activates harmful
phospholipases, endonucleases, and calpains causing cell
organelleandmembranebreakdown,leadingpredominantly
to a necrotic-like cell death. In delayed cell death, the
initial or milder periods of excitotoxicity can trigger a range
of cellular disturbances such as oxidative stress, protein
synthesis/folding disturbances, mitochondrial dysfunction,
and altered cell signalling. The accumulation of these
cellular disturbances can eventually cause a secondary rise
in intracellular calcium and the activation of cell death
pathways (apoptosis, necrosis, autophagy, and necroptosis),
ultimately leading to the demise of the neuron.
1.2. Cerebral Ischemia and Calcium Dysregulation. Although
the exact mechanisms underlying how neuronal calcium
disturbances lead to cell death have not been fully elucidated,
the major pathways responsible for calcium overload during
and following ischemia are better characterised. Ultimately,
calcium dysregulation and overload occur when there is a
disequilibrium concerning homeostatic pathways control-
ling calcium inﬂux, eﬄux, and release from intracellular
organelles.
The major pathways involved in ischemia-associated
neuronal calcium inﬂux are the glutamate receptor channels
(divided into two subtypes: the ionotropic receptors NMDA,
AMPA, and KA and the metabotropic receptors mGluR),
voltage-dependent calcium channels (VDCCs), and the
sodium calcium exchanger (NCX) [2, 3]. More recently,
transient receptor ion channels (TRPM and speciﬁcally
TRPM7) [4], acid-sensing ion channels (ASIC) [5], and2 Stroke Research and Treatment
inward excitotoxic injury current (IEIC)–calcium-permeable
channels [6] have also been implicated in calcium inﬂux.
In addition, the release of calcium from organelles, namely
the mitochondria and endoplasmic reticulum (ER), can
also contribute to neuronal intracellular calcium overload
following ischemia [7, 8].
With respect to calcium eﬄux, there are only two
known mechanisms: via the calcium ATP-ase pump (plasma
membrane calcium ATPase pump (PMCA)) and through
sodium calcium exchanger (NCX) exit mode activity [9]
(Figure 1). Taken together, here lie a number of possible
therapeutic targets to manipulate intracellular calcium levels
afteranischemicepisodeandtherebyreduceneuronaldeath.
With this in mind, this paper will focus on providing a
concise update of the major modes of calcium inﬂux, eﬄux,
and release from organelles following cerebral ischemia.
2.ModesofNeuronalIntracellular
CalciumEntry following CerebralIschemia
2.1. Glutamate Receptors. Glutamate receptors are located
on the cytoplasmic membrane of neurons and are activated
following the binding of the neurotransmitter glutamate.
Their main function following glutamate binding is to
cause postsynaptic excitatory transmission; however, fol-
lowing ischemia their over stimulation can be damaging
to neurons. Glutamate receptors can be divided into two
broadgroupsbasedonselectiveaﬃnityfordiﬀerentagonists:
(1) Ionotropic glutamate receptors which include N-methyl-
D-aspartic acid (NMDA) receptors, α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors and
kainic acid (KA) receptors; and (2) the metabotropic gluta-
mate receptors (mGluR), which are activated selectively by
quisqualate (an agonist of mGluR). Metabotropic receptors,
unlike ionotropic receptors, do not form an ion channel but
rather interact with other receptors on the cell membrane
and are linked to G-protein activation of phospholipase
C, which converts phosphotidylinositol bisphosphate in the
cell membrane to inositol trisphosphate and diacylglycerol.
Inositol trisphosphate acts to release calcium from the ER,
whilst diacylglycerol activates protein kinase C (PKC) which
mediatesmanyeﬀects.Thereleaseofcalciumionsisrequired
for activation of calcium-dependent PKC isoforms; likewise,
PKC can phosphorylate proteins that can then alter calcium
signalling.
With respect to ionotropic glutamate receptors during
ischemia, excessive activation of NMDA and AMPA gluta-
mate receptors is a major source of calcium inﬂux [10–
14]. Likewise, activation of certain metabotropic glutamate
receptor subtypes can cause the release of calcium from the
ER [15].
2.1.1.NMDAReceptors. TheNMD Areceptorisanonspeciﬁc
cation channel with a high aﬃnity for calcium ions. It
is comprised of a four peptide subunit structure with
several diﬀerent subunits being identiﬁed (NR1, NR2A-D,
and NR3) [16]. Activation of this receptor by extracellular
glutamate results in neuronal membrane depolarisation and
VDCCs-mediated calcium inﬂux, as well as calcium inﬂux
through the channel itself. Hence, excessive activation of
these receptors and the resulting calcium-associated inﬂux
would have direct and indirect damaging eﬀects within the
cell. Moreover, it appears that the subcellular location of
NMDA receptors, which can be either synaptic (segregated
onandaroundthesynapse)orextrasynaptic(locatedoutside
of the synaptic cleft) plays an important role in terms of
neuronal fate following activation. NMDA receptors which
contain the NR2A subunits have been shown to be located
primarily in the synapse, whilst those receptors containing
the NR2B subunits are located predominantly in the extra-
synaptic zones of neurons [17].
(1) Synaptic NMDA receptor activation. Recent evidence has
shown that activation of synaptic NMDA receptors is associ-
ated with a prosurvival response in neurons. This response,
whichhasmainlybeencharacterisedusingculturedneurons,
is trigged by a mild nondamaging level of NMDA receptor
activation. The prosurvival response is associated with the
upregulation of prosurvival proteins (e.g., BCL6, BTG2)
and downregulation of prodeath proteins (e.g., CASP8AP2,
DIDO1) [18].
(2) Extrasynaptic NMDA receptor activation. In contrast
to synaptic NMDA activation, overstimulation of extra-
synaptic receptors triggers a neuronal damaging signalling
response. For example, stimulation of extra-synaptic NMDA
receptors can mediate upregulation of the CLCA1 (calcium-
activated chloride channel)and activation of p38 (mitogen-
activated protein kinase p38) both of which contribute to
neuronal death [18–20].
In addition to NMDA receptor subcellular location,
receptor subunit composition is also important in deter-
mining neuronal fate following cerebral ischemia [21]. It
has been demonstrated that following ischemia and NDMA
receptor activation, NR2A and NR3 subunit containing
receptors promote neuronal survival signalling pathways
[14, 22, 23], while NR2B-containing receptors mediate
neuronal death signals [24–28]. With respect to neuronal
death signalling, this can involve interaction of the intra-
cellular domain of the NR2B subunits with proteins such
as DAPK1 (death-associated protein kinase 1) and PSD-95
(postsynaptic density protein 95) or downstream activation
o fp r o t e i n s ,s u c ha sS R E B P - 1( s t e r o lr e g u l a t o r ye l e m e n t -
binding protein-1) [27, 28]. DAPK1 and SREBP-1 activa-
tion is associated with apoptotic cell death, while PSD-95
signalling is associated with nitric oxide production. The
prosurvival eﬀects mediated by NR2A and NR3 subtypes are
less well characterised, but are probably associated with the
regulation of neuroprotective and neurodamaging proteins
as described in Zhang et al. [18].
2.1.2. AMPA Receptors. AMPA receptors are nonspeciﬁc
cation channels that consist of four subunits (GluR1-4),
with receptor permeability to calcium dependent on the
conﬁguration of the subunits [29, 30]. AMPA assemblies
that contain the GluR1, GluR3, and GluR4 subunits are
permeable to calcium ions, while GluR2 subunit containing
assemblies are impermeable to calcium [11, 30]. To this end,Stroke Research and Treatment 3
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Figure1:Modesofcalciumentryandexitintoneuronsfollowingcerebralischemia.Modesofcalciumentry(topofcelldiagram)areVDCCs
(voltage-dependent calcium channel), glutamate receptors (NMDA, AMPA, KA, and mGluR), SOCE (store-operated intracellular calcium
entry), TRP (transient receptor potential channels), ASIC (acid-sensing ion channels), IEIC (inward excitotoxic injury current calcium-
permeable channels), and NCX (sodium-calcium exchanger operating in entry mode). Calcium can also be sequestered intracellularly
(middle of cell diagram) by the mitochondria and ER (endoplasmic reticulum). Modes of calcium exit (bottom of cell diagram) are PCMA
(Calcium ATPase pump) and NCX (sodium-calcium exchanger operating in exit mode).
downregulation of GluR2 protein expression following cere-
bral ischemia is associated with intracellular calcium and/or
zinc inﬂux and neuronal degeneration [13]. In addition, it
is likely that activation of low calcium-permeable AMPA
receptors exerts indirect neurodamaging eﬀects following
ischemia due to their role in VDCCs-mediated calcium
inﬂux.
2.1.3. KA Receptors. KA receptors consist of a four subunit
structure containing a combination of one or more of
ﬁve diﬀerent subunits (KA1, KA2, and GluR5-7). Receptor
subunit composition determines receptor permeability and
function. KA receptors are normally permeable to sodium
and potassium ions and generally not permeable to calcium
[31]. Their role in neuronal fate following ischemia is not
well understood, but there is evidence that their activa-
tion can stimulate survival pathways through regulation
of the inhibitory neurotransmitter, γ-aminobutyric acid
(GABA). For example, it is considered that the post-synaptic
KA receptor-mediated release of GABA activates GABA
receptors, causing inhibition of ischemia-induced NMDA
overactivation [32–36].
2.1.4. Metabotropic Glutamate Receptors. Metabotropic glu-
tamate receptors can be divided into three diﬀerent fam-
ilies with subtypes for each group consisting of: Group I
(mGluR1, mGluR5), Group II (mGluR2, mGluR3), and
Group III (mGluR4, mGluR6-8). Due to metabotropic
receptor-mediated release of calcium from the ER these
receptors can contribute to increased intracellular calcium
following ischemia. However, it has also been demonstrated
thatmetabotropicglutamatereceptoragonistscanbeprotec-
tive following ischemia [37–41].
2.2. Voltage-Dependent Calcium Channels. Voltage-depend-
ent calcium channels (VDCCs) are a type of transmembrane
ion channel found in excitable cells and are composed of
four homologous α1 transmembrane subunits which form a
calcium-permeableporealongwithα2δ,β1−4,andγ auxiliary
subunits which function in modulating the channel com-
plex [42]. There exist several structurally related subtypes,
including L-type, N-type, P/Q-type, and T-type. During an
ischemic event, neuronal membrane depolarisation results
in the activation of these channels and intracellular calcium
inﬂux.
2.2.1. L-Type VDCCs. L-type VDCCs (otherwise known as
long-lasting or DHP receptors) are commonly found on
dendriticneuronsand,whenactivated,triggercalciuminﬂux
and the expression of genes leading to cell survival [10].
However, during the early phases of ischemia and reperfu-
sion, L-type channel activation is likely to contribute to cal-
cium dysregulation and cell death, as their inhibition before
or early after cerebral ischemia is neuroprotective [43, 44].
Interestingly, in the later stages after ischemia/reperfusion
L-type channels are downregulated [43], a process that4 Stroke Research and Treatment
is thought to contribute to delayed neuronal death, as
the administration of channel agonists in late postischemia
settings is neuroprotective [43, 45].
2.2.2. N-Type VDCCs. N-type VDCCs (otherwise known
as neural) play a primary role in neurotransmitter release
from the presynaptic terminal via the inﬂux of calcium
after depolarisation. The toxin ´ ω-conotoxin is a speciﬁc
blocker of these channels and is regularly used to study their
function and mechanisms. Early studies [46–49] revealed
thatasyntheticpeptide,SNX-111(aselectiveN-typeVDCCs
blocker), was found to be highly neuroprotective following
global cerebral ischemia, suggesting that N-type calcium-
channels play an important role in calcium associated
ischemia and neuronal injury.
2.2.3. P/Q-Type VDCCs. P/Q-type VDCCs (or Purkinje)
are found mainly in the cerebellum and are involved
in presynaptic neurotransmitter release. Blockade of these
channelswiththe ´ ω-agatoxinhasbeenshowntoreducebrain
infarcts following focal cerebral ischemia [50].
2.2.4. T-Type VDCCs. T-type VDCCs (or transient) are
associated with low-voltage activity in the brain and activate
when the neurons are at rest (∼− 60mV) allowing small
amounts of calcium inﬂux, which have been shown to
beneﬁt signal ampliﬁcation. Speciﬁc inhibitors of these
channels have been shown to dramatically reduce neuronal
damage in hippocampal slice cultures following oxygen-
glucose deprivation [51].
2.3. Transient Receptor Potential Channels. Transient recep-
tor potential (TRP) channels are a family of cation channels
which are nonselective for ions such as magnesium, sodium,
and calcium. TRP channels consist of six transmembrane
segments with pore formation between segments 5 and 6
[52]. In mammals, they can be divided into six subfam-
ilies: TRPC (canonical), TRPV (vanilloid), TRPM (melas-
tatin), TRPP (polycystin), TRPML (mucolipin), and TRPA
(ankyrin) [53]. TRP channels have been associated with
many diﬀerent diseases and have been implicated in some
kidney and heart disease whilst also playing an important
role in cerebral ischemia [4, 54].
Of particular interest for this paper are the TRPM and
TRPCfamily,members.WithintheTRPMfamilythereexists
eight subtypes (TRPM1-8). Of these subtypes the TRPM7
and to a lesser extent TRPM2 members are the most impor-
tant with respect to ischemia-induced neuronal calcium
inﬂux [55], as these receptors are activated by oxidative
mechanisms which are increased during ischemia and result
in large intracellular calcium inﬂuxes. Downregulation of
TRPM7 is neuroprotective following global ischemia [56].
TRPC channels can be divided into four main subgroups
(TRPC1, TRPC2, TRPC3/6/7, and TRPC4/5), and they are
thought to play an important role in regulating the reﬁlling
of the intracellular calcium stores after phospholipase C-
induced calcium release. After calcium release, a proportion
of the released calcium is pumped out of the neuron due to
the activity of the plasmalemmal calcium extrusion systems,
making it unavailable for reuptake by the calcium store. The
TRPC channels are activated by calcium store depletion, and
the ensuing calcium entry provides the calcium necessary
for complete reﬁlling of the calcium store [57, 58]. It
has been shown that TRPC channels, in particular the
TRPC1 form, have increased expression in hippocampal
organotypic slices following glutamate exposure, and their
activation contributes to neuronal cell death [59]. It has also
been shown that TRPC1 is activated by the metabotropic
glutamate receptor mGluR1 [60]. Hence, it is reasonable
to conclude that these receptors are likely to contribute to
neuronal intracellular calcium inﬂux following ischemia.
2.4. Acid-Sensing Ion Channels. Acid-sensing Ion Channels
(ASIC) are nonselective ion channels, which are activated in
response to decreased extracellular pH. These trimeric chan-
nels consist of one or more of six diﬀerent subunits (ASIC1a,
ASIC1b, ASIC2a, ASIC2b, ASIC3, and ASIC4), which vary in
their response to pH levels. In the event of cerebral ischemia,
the resulting extracellular pH decrease triggers ASIC channel
opening, allowing calcium to enter neurons [61]. It has been
reported that pharmacological blockade or gene knockdown
of ASIC in stroke models attenuates neuronal injury [62,
63]. Although both ASIC1a and ASIC2a subunits are found
abundantly in the brain, ASIC1a containing channels are
consideredtoplayamajorroleincalcium-mediatedischemic
brain injury [64]. Furthermore, it has been demonstrated
that NR2B-containing NMDA receptors can activate the
calcium/calmodulin-dependent protein kinase II (CaMKII)
pathway causing the phosphorylation of the ASIC1a channel
leading to acidotoxicity-induced cell death [65].
2.5. Sodium-Calcium Exchanger (Calcium Entry Mode). The
sodium-calcium exchanger (NCX) is a bidirectional ion
transporter,withalowaﬃnitybuthightransportingcapacity
for calcium. Its structure consists of nine transmembrane
segments which are involved in binding and transportation
of sodium and calcium ions and a large intracellular
hydrophilic loop which functions to regulate NCX activity
[66]. There exist three isoforms (NCX1, NCX2, and NCX3),
all of which are expressed in the brain. Under normal
physiological conditions, NCX’s main function is to expel
calcium out of the cell (forward or calcium exit mode)
whilst concurrently transporting sodium into the cell by
using the electrochemical gradient of the sodium ions.
However, under certain pathological conditions such as
cerebral ischemia, NCX can operate in reverse or calcium
entry mode, promoting potentially damaging calcium inﬂux
[2, 67]. Here lies conﬂicting opinions as to whether NCX is
neuroprotective or neurodamaging.
One working model is that under severe ischemic condi-
tions,theNCXoperatesincalciumentrymodeandfacilitates
calcium-induced acute neuronal cell death. Under these
conditions-blocking NCX activity is neuroprotective [68–
70]. In contrast, during or after milder episodes of cerebral
ischemia, which normally results in neuronal recovery of
delayed neuronal death, the NCX operates in calcium exit
mode in an attempt to restore calcium homeostasis [71–73].
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inactivation of NCX3 can occur following cerebral ischemia,
rendering the channel inactive and resulting in reduced
calcium eﬄux, contributing to calcium dysregulation and
cell death [74].
2.6. Inward Excitotoxicity Injury Current (IEIC)—Calcium-
Permeable Channel. Ar e c e n ts t u d y[ 6]h a sd e s c r i b e da
novel calcium-permeable channel in cultured hippocampal
neurons identiﬁed as the inward excitotoxic injury chan-
nel (IEIC), which the authors believe is also responsible
for glutamate-induced extended neuronal depolarisation
(END) and calcium-mediated excitotoxicity. Based on in
vitro experimental studies, the IEIC is activated after an
excitotoxic insult, and once activated results in sustained
neuronal calcium entry. Further investigations showed that
blocking of the IEIC by gadolinium following excitotoxicity
attenuated sustained calcium inﬂux and prevented neuronal
death. Additional studies, including in vivo experiments,
are needed to clarify the characteristics, structure, and
exact function of this channel in neurons following cerebral
ischemia.
2.7. Intracellular Calcium Sequestering and Release:
Release from Mitochondria and Endoplasmic Reticulum
2.7.1. Mitochondria. In excitable cells such as neurons,
mitochondria play a role in regulating intracellular calcium
levels [75, 76] .I nn e u r o n s ,o n ew a yt h i si sa c h i e v e di s
through the exchange of calcium ions from the matrix for
cytosolicsodiumionsviathemitochondrial sodium/calcium
exchanger (NCXMITO), located in the inner mitochondrial
membrane [77, 78]. There is also an interplay between
NMDA-induced calcium stimulation, mitochondrial seques-
tering, and NCXMITO suggesting that calcium is recycled
across the mitochondrial membrane of neurons via the
NCXMITO in response to overstimulation of the NMDA
receptors
However, mitochondria have a limit to the amount
of calcium that can be sequestered and this limitation is
also inﬂuenced by the metabolic status of the cell. Thus,
while mitochondrial calcium sequestration is a protective
response, once this system becomes overwhelmed, it has
severe consequences for the cell, leading to the activation
of proapoptotic proteins and eventual cell death. Therefore
following cerebral ischemia, the inability of mitochondria to
adequately buﬀer neuronal intracellular calcium can result
in calcium dysregulation [7, 79]. In addition, mitochondria
can undergo other changes, which are damaging to the cell
such as the loss of the mitochondrial membrane potential,
increased mitochondrial membrane permeability, release of
cytochrome C (a proapoptotic protein which in turn causes
release of ER calcium stores) and excessive reactive oxygen
species production [80].
2.7.2. Endoplasmic Reticulum. T h eE Rs e r v e sa sas t o r a g e
facility for calcium in neurons and other cells. The ER
plays a fundamental homeostatic role during and following
cerebral ischemia, by sequestering excess cytosolic calcium,
which is thought to prevent ER stress and thus provide
a protective mechanism against cell death [8]. However,
when overwhelmed, ER homeostasis becomes dysregulated,
resulting in subsequent calcium release, which contributes
to calcium-associated cell death processes [81]. Normally,
ER calcium inﬂux is controlled by the Ca2+-ATPase pump
located on the ER membrane, but during and following
ischemia, its function in neurons is compromised due
to declining ATP levels. Furthermore, cerebral ischemia
activates phospholipase C causing hydrolysis of PIP2 (phos-
phatidylinositol (4, 5) bisphosphate) to release the signalling
molecule IP3 (inositol (1-,4-,5-) trisphosphate). Receptors
for IP3 (inositol (1-,4-,5-)trisphosphate receptors IP3Rs)a r e
located on the ER membrane and function as ligand-gated
channels [81, 82]. Activation of P3Rs by IP3 results in a rapid
release of calcium from the ER. Similarly, ryanodine receptor
(RyRs) calcium release channels located on ER membranes
are also likely to be activated following cerebral ischemia
resulting in additional release of calcium via these channels
[82].
2.8. Store-Operated Intracellular Calcium Entry. Store-oper-
ated calcium entry (also called capacitative calcium entry)
refers to an inﬂux of extracellular calcium across the plasma
membrane via store-operated calcium channels (e.g., ORAI,
TRP channels) in response to ER intracellular calcium
release and store depletion [83]. Recently, this calcium
entry mechanism has been demonstrated to occur following
cerebral ischemia and contribute to neuronal death [84].
In neurons, the activation of store-operated channels is
regulated by the ER transmembrane sensing protein STIM2
(stromal interaction molecule), which when activated inter-
acts with and stimulates store-operated calcium channels.
Berna-Erro et al. [84] have shown that neurons from STIM2
knockout mice are more resistant to hypoxia, and that
the mice display less neurological damage following focal
ischemia.
3.NeuronalIntracellularCalciumHomeostatic
Mechanisms following Cerebral Ischemia
3.1. Calcium ATP-ase Pump. The calcium ATPase pump (or
Plasma Membrane Calcium ATPase pump; PMCA) serves
to regulate intracellular calcium levels by actively expelling
calcium out of the cell. It has a high aﬃnity but low
transporting capacity for calcium. Its structure consists of
ten transmembrane domains which forms the calcium-
permeable pore and three intracellular loops which regulate
its activity [85]. It is driven by ATP, with one calcium ion
being removed for every ATP molecule hydrolysed. There
are four PMCA isoforms (PMCA 1-4) with PMCA2 and
PMCA3, mostly conﬁned to the brain. During cerebral
ischemia, reduced ATP generation results in compromised
PMCA activity [86]. In addition, ischemia-induced caspase
activation can cleave and inactive PMCA in neuronal cells
allowing calcium overload [87]. Therefore, while the PMCA
is an important neuronal calcium extrusion mechanism,
its activity can be severely impeded by the intracellu-
lar biochemical changes that occur in neurons following
ischemia.6 Stroke Research and Treatment
3.2. Sodium Calcium Exchanger (Calcium Exit Mode). Under
normal physiological conditions NCX acts as a calcium
extrusion transporter by operating in the forward or calcium
exit mode [88]. As mentioned above, while there may be
circumstances when it operates in calcium entry mode in
neurons following cerebral ischemia; it is likely to be the
major calcium eﬄux mechanism in cells that recover from
the initial ischemia insult and in which the exchanger has
not been severely inactivated by calpain cleavage [74]. For
example,ithasbeenshownthatoverexpressionofthecalpain
resistant NCX2 isoform, but not calpain sensitive NCX3
isoform in cerebellar granule neuronal cultures reduces
glutamate-induced calcium inﬂux and neuronal death [89].
The beneﬁcial eﬀects of NCX activity following cerebral
ischemia are further supported by data showing that NCX
knockout mice suﬀer more brain injury following both
global and focal cerebral ischemia [72, 73].
4. Summary
Excessive intracellular calcium inﬂux is a major instigator
of neuronal cell death following cerebral ischemia. This
inﬂux is mediated by a number of important channels
and transporters. In addition, the overload of calcium in
intracellular stores and the subsequent release of calcium
from these stores can further exacerbate the problem. In
contrast, there are only two known mechanisms to allow
calcium exit (PMCA and NCX), both of which are suscep-
tible to biochemical and/or proteolytic inactivation caused
by intracellular disturbances associated with ischemia. This
imbalance proves to be a major downfall in a neuron’s ability
to maintain calcium homeostasis following ischemia, which
ultimately contributes to its demise.
While researchers have made signiﬁcant progress in
understanding these important calcium inﬂux and eﬄux
pathways, especially under pathological conditions such as
cerebralischemia,ithasnottranslatedintoanyclinicalthera-
peutic neuroprotective agents. However, it is anticipated that
further investigation of calcium inﬂux and eﬄux pathways
will eventually enable the design of drugs to manipulate
neuronal intracellular calcium levels following ischemia and
lead to new neuroprotective therapies.
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